TITLE:
A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)

CONDITION:
Osteoarthritis

INTERVENTION:
MK0663, etoricoxib

SUMMARY:

      The purpose of this study is to compare the safety and effectiveness of an investigational
      drug and an approved drug in the treatment of osteoarthritis of the knee and hip.
    

DETAILED DESCRIPTION:

      The duration of treatment is 26 weeks.
    

ELIGIBILITY:
Gender: All
Age: 40 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Osteoarthritis of the knee or hip which requires treatment with medication for pain
             relief

        Exclusion Criteria:

          -  Any known allergies to the study drugs
      
